HAVCR2 and amyotrophic lateral sclerosis: In contrast to the decrease in the numbers of CD14−/low/CD16+ monocytes from patients with ALS, the frequency of CD14−/low/CD16+/TIM-3+ monocytes was increased in both PBMC and isolated pan-monocytes from fast progressing patients.